Metabolic Impact Retatrutide improves the bodys ability to utilize glucose, allowing it to maintain better blood sugar control even in those without diabetes
The emphasis is always on patient safety, realistic goals, and long term success
02 Meet with our expert team to discuss your goals, explore options, and design a customized treatment plan that supports both confidence and wellness
Retatrutide stands out because it affects three hormone receptors at once: GLP-1, GIP, and glucagon
Their supervision aids guarantee treatment is secure and profitable for each patient
In a 48-week phase 2 trial published in The New England Journal of Medicine , adults with obesity (without type 2 diabetes) receiving once-weekly subcutaneous retatrutide at the 12 mg amount achieved a least-squares mean body weight reduction of 24.2%, compared with 2.1% in the placebo group [1]